Schering AG files patent infringement lawsuit against Barr Laboratories, Inc. and Barr Pharmaceuticals, Inc.
Yasmin® is the subject of an Abbreviated New Drug Application. Barr Laboratories, Inc. is currently seeking approval from the United States Food and Drug Administration to produce and market a generic version of Yasmin®.
The patent infringement lawsuit by Schering AG and Berlex, Inc. was filed in the United States District Court for the District of New Jersey.
Other news from the department research and development
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.